Craig H Mallinckrodt

Points to consider for analyzing efficacy outcomes in long‐term extension clinical trials

Bohdana Ratitch, Ilya Lipkovich, Janelle Shannon Erickson, 2018, Pharmaceutical statistics.

The impact of missing data and how it is handled on the rate of false‐positive results in drug development

Craig H Mallinckrodt, Stacy R Lindborg, Sunni A Barnes, 2008, Pharmaceutical statistics.

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

Geert Molenberghs, Craig H Mallinckrodt, Raymond J Carroll, 2003, Biological Psychiatry.

The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA

Geert Molenberghs, Craig H Mallinckrodt, Raymond J Carroll, 2004, Clinical trials.

Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials.

Craig H Mallinckrodt, Yoko Tanaka, R. Tamura, 2011, Journal of psychiatric research.

A Multiple-Imputation-Based Approach to Sensitivity Analyses and Effectiveness Assessments in Longitudinal Clinical Trials

Geert Molenberghs, Craig H Mallinckrodt, Ilya Lipkovich, 2014, Journal of biopharmaceutical statistics.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Craig H Mallinckrodt, Maurizio Fava, M. Fava, 2004, The Journal of clinical psychiatry.